60 Degrees Pharmaceuticals, Inc.
Price Action
Technical Summary
DOWNTREND60 Degrees Pharmaceuticals, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is moderate (RS Rating: 75), indicating performance broadly in line with the market. Earnings growth of 25% provides fundamental context to the price action. Investors should exercise caution due to high volatility (122% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.74 | -4.60% | BELOW |
| 50 SMA | $1.97 | -15.89% | BELOW |
| 100 SMA | $2.58 | -35.75% | BELOW |
| 150 SMA | $3.42 | -51.51% | BELOW |
| 200 SMA | $3.93 | -57.78% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SXTP in an uptrend right now?
SXTP has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is SXTP overbought or oversold?
SXTP's RSI (14) is 44. The stock is in neutral territory, neither overbought nor oversold.
Is SXTP outperforming the market?
SXTP has a Relative Strength (RS) Rating of 75 out of 99. SXTP is performing about average compared to the market.
Where is SXTP in its 52-week range?
SXTP is trading at $1.66, which is 19% of its 52-week high ($8.62) and 16% above its 52-week low ($0.34).
How volatile is SXTP?
SXTP has a Beta of 1.96 and 52-week volatility of 122%. It's more volatile than the S&P 500 - expect bigger swings.